US Patent 10272116 Immunocompatible amniotic membrane products
Patent 10272116 was granted and assigned to Osiris Therapeutics on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10272116 Immunocompatible amniotic membrane products
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
